CIFoundry
Back to Catalog
Neurology
FDA Cleared

Persyst 15 EEG Review and Analysis

Save to shortlist
Persyst Development Corporation

Last reviewed Oct 31, 2026 against the sources listed on this page · How we review

At a glance

Persyst 15 is EEG review software that uses neural-network algorithms to detect seizures and spikes and produce trends for continuous EEG monitoring.

FDA:
510(k) K252160 +2 more
Epic:
Not on record
Named users:
Not on record
Published study:
Not on record

Description

Persyst 15 is EEG review software that uses neural-network algorithms to detect seizures and spikes and produce trends for continuous EEG monitoring. Latest FDA 510(k) K252160, October 2025.

Quick answers

Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review

Is Persyst 15 EEG Review and Analysis FDA cleared?
The public FDA database has 3 records that our team matched to Persyst 15 EEG Review and Analysis. The most recent is 510(k) K252160 (Persyst 15 EEG Review and Analysis Software (Persyst 15 (P15))), decided Oct 2025. Check that the cleared use matches how you plan to use it.FDA record K252160

Security & contracting

The maker has not reported these details yet. Ask the vendor directly during evaluation.

Workflow stage
Not reported
Integrations
Not reported
Data inputs
Not reported
Deployment
Not reported
Signs a BAA
Not reported
SOC 2 report
Not reported
HITRUST
Not reported
Evidence type
Not assessed

Readiness details are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.

Who's using this

Organizations named in public announcements or by the developer. Inclusion is not an endorsement.

No public deployments found yet (checked Oct 2026). Using this tool? The maker can claim the listing to add customers.

Get weekly updates for Neurology

Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.

Sources

This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.

Website

FDA database records

  • K252160 · 510(k) · Oct 2025
    Persyst 15 EEG Review and Analysis Software (Persyst 15 (P15))
  • K242446 · 510(k) · Jan 2025
    Persyst 15 EEG Review and Analysis Software (Persyst 15 (P15))
  • K222002 · 510(k) · Dec 2022
    Persyst 15 EEG Review and Analysis Software

Matched by our team from the public FDA database; checked Nov 10, 2026.

History (4)Show

Dated events on this listing's public record, newest first.

  1. Oct 31, 2026

    Added to CIFoundry

  2. Oct 31, 2025

    FDA 510(k) K252160 decision datesource

  3. Jan 22, 2025

    FDA 510(k) K242446 decision datesource

  4. Dec 30, 2022

    FDA 510(k) K222002 decision datesource

Developer

Persyst Development Corporation

Evaluating this tool?

Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.

Prepare evaluation packet

Checklist for your role: Admin · Physician · IT · Compliance

Compare similar tools →

Own this tool?

Claim this listing to update its details and connect with your audience.